Paul L. Boyer, Ph.D.

Staff Scientist

Team Member of:

Dr. Paul Boyer is a staff scientist in the HIV Drug Resistance Program.

Areas of Expertise

1) identification and characterization of HIV-1 inhibitors, 2) reverse transcriptase

Contact Info

Paul L. Boyer, Ph.D.
Center for Cancer Research
National Cancer Institute
Building 539, Room 116
Frederick, MD 21702-1201
Ph: 301-846-1611
View Dr. Boyer's Full PubMed Summary.

Selected Recent Publications

  1. Ivetac A, Swift SE, Boyer PL, Diaz A, Naughton J, Young JA, Hughes SH, McCammon JA.
    Chem Biol Drug Des. 83: 521-31, 2014. [ Journal Article ]
  2. Dunn LL, Boyer PL, Clark PK, Hughes SH.
    Virology. 444: 241-9, 2013. [ Journal Article ]
  3. Boyer PL, Clark PK, Hughes SH.
    J Virol. 86: 5885-94, 2012. [ Journal Article ]
  4. Vu BC, Boyer PL, Siddiqui MA, Marquez VE, Hughes SH.
    Antimicrob Agents Chemother. 55: 2379-89, 2011. [ Journal Article ]
  5. Lee EG, Roy J, Jackson D, Clark P, Boyer PL, Hughes SH, Linial ML.
    J Virol. 85: 1655-61, 2011. [ Journal Article ]

Dr. Paul Boyer obtained his Ph.D. in Biochemistry at Michigan State University in 1988. After postdoctoral training in the ABL-Basic Research Program at the NCI-Frederick Cancer Research and Development Center, he was promoted to a Scientist Associate in 1997. Dr. Boyer joined the HIV Drug Resistance Program, National Cancer Institute, as a Staff Scientist in 1998.